{"id":668,"date":"2020-07-17T12:53:30","date_gmt":"2020-07-17T11:53:30","guid":{"rendered":"http:\/\/www.testingforall.org\/?page_id=668"},"modified":"2021-04-16T23:37:36","modified_gmt":"2021-04-16T22:37:36","slug":"participant-information","status":"publish","type":"page","link":"https:\/\/www.testingforall.org\/participant-information\/","title":{"rendered":"Participant Information"},"content":{"rendered":"
An observational study assessing the presence and level of IgG antibody response to the spike protein of SARS-CoV-2 generated by natural infection and following vaccination<\/span><\/p>\n Testing For All offers affordable and accessible testing, and enables an individual to access highly accurate laboratory based testing to better understand their unique health and risk status.<\/span><\/p>\n After an individual has tested with us we invite users to this observational study to provide further information. This provides context to the results, and lets an individual see if their immune response is typical. It is known that vaccines do fail for various reasons, including issues with manufacture, transport and storage; but also how the individual\u2019s body responds<\/span><\/p>\n Participants will be required to answer a series of questions in an online form<\/span><\/p>\n By taking part you will contribute to one of the most advanced observational studies for quantitative IgG response, and hence better inform your own situation and the community of people that choose to test with Testing For All. It is also hoped that this body of data will further inform public policy<\/span><\/p>\nBackground Information<\/span><\/h3>\n
What does taking part involve?<\/span><\/h3>\n
What are the benefits of taking part?<\/span><\/h3>\n
What are the risks of taking part?<\/span><\/h3>\n